medigraphic.com

2018, Number 1

<< Back Next >>

Cir Cir 2018; 86 (1)

Urological manifestations of the disease related to immunoglobulin G4

Carrillo-Córdova LD, Carrillo-Córdova CA, Vitar-Sandoval J, Jaspersen-Álvarez J, Villena-López EL, Carrillo-Esper R

Language: Spanish
References: 87
Page: 63-70
PDF size: 396.03 Kb.


ABSTRACT

Immunoglobulin G4 related disease (IgG4-RD) is a fibro-inflammatory disease of unknown etiology, characterized by lesions in the form of tumors, elevated serum IgG4 levels, plasma cells with significant IgG4 infiltration, accompanied by phlebitis obliterans and fibrosis. This disease usually has multiorgan disease, including pancreas, biliary tract, salivary glands, peri orbital tissues, kidneys, lungs, lymph nodes and retro peritoneum. IgG4-RD mainly affects men with a predominance of age by young adults until old age. The clinical manifestations of IgG4-RD, depend mainly on the organs affected and the response to steroids. His forecast is not yet clear. Within the affected urogenital organs can be observed kidney, retroperitoneum, ureter, bladder, urachus, testis/epididymis, paratesticular region, prostate and urethra.


REFERENCES

  1. Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4- related autoimmune disease. J Gastroenterol. 2003;38:982-4.

  2. Masaki Y, Dong L, Kurose N, et al. Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis. 2009;68:1310-5.

  3. Kamisawa T, Shimosegawa T, Okazaki K, et al. Standard steroid treatment for autoinmune pancreatitis. Gut. 2009;58:1504-7.

  4. Hart PA, Kamisawa T, Brugge WR, et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut. 2013;62:1771-6.

  5. Inoue D, Yoshida K, Yoneda N, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine (Balt). 2015;94:e680.

  6. Wallace ZS, Deshpande V, Mattoo H, et al. IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients. Arthritis Rheum (Munch). 2015;67:2466-75.

  7. Kawano M, Saeki T, Nakashima H, et al. Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol. 2011;15 615-26.

  8. Stone JH, Khosroshahi A, Deshpande V, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012;64:3061-7.

  9. Raissian Y, Nasr SH, Larsen CP, et al. Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol. 2011;22:1343-52.

  10. Takahashi N, Kawashima A, Fletcher JG, Chari ST. Renal involvement in patients with autoimmune pancreatitis: CT and MR imaging findings. Radiology. 2007;242:791-801.

  11. Inoue D, Kawano M, Yamada K. Kidney and urinary tract lesions. En: Umehara H, Okazaki K, Stone JH, Kawa S, Kawano M, editores. IgG4-related disease. Tokyo: Springer Japan; 2014. p. 99-105.

  12. Kim SA, Lee SR, Huh J, et al. IgG4-associated inflammatory pseudotumor of ureter: clinicopathologic and immunohistochemical study of 3 cases. Hum Pathol. 2011;42:1178-84.

  13. Abe H, Morikawa T, Araki A, et al. IgG4-related periureteral fibrosis presenting as a unilateral ureteral mass. Pathol Res Pract. 2011; 207:712-14.

  14. Kim S, Kim TG, Choi SK, et al. Immunoglobulin G4-related systemic sclerosing disease: a case involving the ureter and kidney. Korean J Urol. 2013;54:209-11.

  15. Marando A, D’Ambrosio G, Catanzaro F, et al. IgG4-related disease of the ureter: report of two cases and review of the literature. Virchows Arch. 2013;462:673-8.

  16. Moriarty MA, Dahmoush L, Nepple KG. IgG4 related disease of the ureter (inflammatory pseudotumor). J Urol. 2014;191:1126-7.

  17. Della Torre E, Mattoo H, Mahajan VS, et al. Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease. Allergy. 2014; 69:269-72.

  18. Chen H, Lin W, Wang Q, et al. IgG4-related disease in a Chinese cohort: a prospective study. Scand J Rheumatol. 2014;43:70-4.

  19. Nirula A, Glaser SM, Kalled SL, et al. What is IgG4? A review of the biology of a unique immunoglobulin subtype. Curr Opin Rheumatol. 2011;23:119-24.

  20. Tanaka A, Moriyama M, Nakashima H, et al. Th2 and regulatory immune reactions contribute to IgG4 production and the initiation of Mikulicz disease. Arthritis Rheum. 2012;64:254-63.

  21. Tsuboi H, Matsuo N, Iizuka M, et al. Analysis of IgG4 class switch-related molecules in IgG4-related disease. Arthritis Res Ther. 2012;14:R171.

  22. Takeuchi M, Sato Y, Ohno K, et al. T helper 2 and regulatory T-cell cytokine production by mast cells: a key factor in the pathogenesis of IgG4-related disease. Mod Pathol. 2014;27:1126-36.

  23. Shevach EM, DiPaolo RA, Andersson J, et al. The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells. Immunol Rev. 2006; 212:60-73.

  24. Meiler F, Klunker S, Zimmermann M, et al. Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll-like receptors. Allergy. 2008; 63:1455-63.

  25. Satoh-Nakamura T, Kurose N, Kawanami T, et al. CD14+ follicular dendritic cells in lymphoid follicles may play a role in the pathogenesis of IgG4-related disease. Biomed Res. 2015;36:143-53.

  26. Medina F, Segundo C, Campos-Caro A, et al. The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression. Blood. 2002;99:2154-61.

  27. Wallace ZS, Mattoo H, Carruthers M, et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis. 2015;74:190-5.

  28. Mattoo H, Mahajan VS, Della-Torre E, et al. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. J Allergy Clin Immunol. 2014;134:679-87.

  29. Umehara H, Okazaki K, Masaki Y, et al. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol/ Jpn Rheum Assoc. 2012;22:1-14.

  30. Uchida K, Masamune A, Shimosegawa T, et al. Prevalence of IgG4-related disease in Japan based on nationwide survey in 2009. Int J Rheumatol. 2012;2012:358371.

  31. Yamamoto M, Yajima H, Takahashi H, et al. Everyday clinical practice in IgG4- related dacryoadenitis and/or sialadenitis: results from the SMART database. Mod Rheumatol. 2015;25:199-204.

  32. Wallace ZS, Deshpande V, Mattoo H, et al. IgG4-related disease: clinical and laboratory features in 125 patients. Arthritis Rheumatol. 2015;67:2466-75.

  33. Mannion M, Cron RQ. Successful treatment of pediatric IgG4 related systemic disease with mycophenolate mofetil: case report and a review of the pediatric autoimmune pancreatitis literature. Pediatr Rheumatol Online J. 2011;9:1.

  34. Laco J, Podhola M, Kamaradova K, et al. Idiopathic vs. secondary retroperitoneal fibrosis: a clinicopathological study of 12 cases, with emphasis to possible relationship to IgG4-related disease. Virchows Arch Int J Pathol. 2013;463:721-30.

  35. Kalapesi FB, Garrott HM, Moldovan C, et al. IgG4 orbital inflammation in a 5-year old child presenting as an orbital mass. Orbit. 2013;32:137-40.

  36. Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012; 22:21-30.

  37. Kawano M, Saeki T, Nakashima H, et al. Proposal for diagnostic criteria for IgG4- related kidney disease. Clin Exp Nephrol. 2011;15:615-26.

  38. Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011;40:352-8.

  39. Della Torre E, Mattoo H, Mahajan VS, et al. Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease. Allergy. 2014; 69:269-72.

  40. Chen H, Lin W, Wang Q, et al. IgG4-related disease in a Chinese cohort: a prospective study. Scand J Rheumatol. 2014;43:70-4.

  41. Yamamoto M, Takahashi H, Shinomura Y. Mechanisms and assessment of IgG4-related disease: lessons for the rheumatologist. Nat Rev Rheumatol. 2014;10:148-59.

  42. Cheuk W, Yuen HK, Chan AC, et al. Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease. Am J Surg Pathol. 2008;32:1159-67.

  43. Venkataraman G, Rizzo KA, Chavez JJ, et al. Marginal zone lymphomas involving meningeal dura: possible link to IgG4-related diseases. Mod Pathol. 2011;24:355-66.

  44. Takahashi H, Yamamoto M, Tabeya T, et al. The immunobiology and clinical characteristics of IgG4 related diseases. J Autoimmun. 2012;39:93-6.

  45. Kiyama K, Yoshifuji H, Kandou T. Screening for IgG4-type anti-nuclear antibodies in IgG4-related disease. BMC Musculoskelet Disord. 2015;16:129.

  46. Masaki Y, Kurose N, Yamamoto M, et al. Cutoff values of serum IgG4 and histopathological IgG4+ plasma cells for diagnosis of patients with IgG4-related disease. Int J Rheumatol. 2012;2012:580814.

  47. Carruthers MN, Khosroshahi A, Augustin T, et al. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis. 2015;74:14-8.

  48. Katsura M, Mori H, Kunimatsu A, et al. Radiological features of IgG4-related disease in the head, neck, and brain. Neuroradiology. 2012; 54:873-82.

  49. Nakatani K, Nakamoto Y, Togashi K. Utility of FDG PET/CT in IgG4-related systemic disease. Clin Radiol. 2012;67:297-305.

  50. Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25:1181-92.

  51. Cai Y, Li H-Z, Zhang Y-S. IgG4-related inflammatory pseudotumor of the kidney mimicking renal cell carcinoma: a case report. Oncology Letters. 2016;11:3438-40.

  52. Saeki T, Kawano M. IgG4-related kidney disease. Kidney Int. 2014;85:251-7.

  53. Kuroda N, Nao T, Fukuhara H, et al. IgG4-related renal disease: clinical and pathological characteristics. Int J Clin Exp Pathol. 2014;7 6379-85.

  54. Tan TJ, Ng YL, Tan D, et al. Extrapancreatic findings of IgG4 related disease. Clin Radiol. 2014;69:209-18.

  55. Wang Y, Chen X, Luo R, et al. IgG4-related systemic disease mimicking renal pelvic cancer: a rare case. World J Surg Oncol. 2014;12:395.

  56. Yoshino T, Moriyama H, Fukushima M, et al. A case of IgG4-related retroperitoneal fibrosis mimicking renal pelvic cancer. Urol Int. 2012; 90:365-8.

  57. Nishi S, Imai N, Yoshida K, et al. Clinicopathological findings of immunoglobulin G4-related kidney disease. Clin Exp Nephrol. 2011;15:810-9.

  58. Park HG, Kim KM. IgG4-related inflammatory pseudotumor of the renal pelvis involving renal parenchyma, mimicking malignancy. Diagn Pathol. 2017;11:12.

  59. Lei WH, Xin J, Shao CX, et al. IgG4 related kidney disease mimicking malignant ureter tumor: case report and literature review. Medicine (Balt). 2016;95:e2550.

  60. Hara N, Kawaguchi M, Takeda K, et al. Retroperitoneal disorders associated with IgG4-related autoimmune pancreatitis. World J Gastroenterol. 2014;20:16550-8.

  61. Corradi D, Maestri R, Palmisano A, et al. Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis. Kidney Int. 2007;72:742-53.

  62. Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet. 2006; 367:241-51.

  63. Kottra JJ, Dunnick NR. Retroperitoneal fibrosis. Radiol Clin North Am. 1996;34:1259-75.

  64. Zen Y, Kasashima S, Inoue D. Retroperitoneal and aortic manifestations of immunoglobulin G4-related disease. Semin Diagn Pathol. 2012;29:212-8.

  65. Park S, Ro JY, Lee DH, et al. Immunoglobulin G4-associated inflammatory pseudotumor of urinary bladder: a case report. Ann Diagn Pathol. 2013;17:540-3.

  66. Montironi R, Scarpelli M, Cheng L, et al. Immunoglobulin G4-related disease in genitourinary organs: an emerging fibroinflammatory entity often misdiagnosed preoperatively as cancer. Eur Urol. 2013;64:865-72.

  67. Dropkin BM, Ingimarsson JP, Jones JD, et al. Immunoglobulin G4-related disease in the urinary bladder. Int J Urol. 2015;22:605-7.

  68. Dum TW, Zhang D, Lee EK. IgG4-related disease in a urachal tumor. Case Rep Urol. 2014;2014:275850.

  69. Choi JW, Kim SY, Moon KC, et al. Immunoglobulin G4-related sclerosing disease involving the urethra: case report. Korean J Radiol. 2012; 13:803-7.

  70. Williamson SR, Scarpelli M, López-Beltran A, et al. Urethral caruncle: a lesion related to IgG4-associated sclerosing disease? J Clin Pathol. 2013;66:559-62.

  71. Migita K, Miyashita T, Mizuno A, et al. IgG4-related epididymo-orchitis associated with bladder cancer: possible involvement of BAFF/BAFF-R interaction in IgG4-related urogenital disease. Mod Rheumatol. 2014; 24:188-94.

  72. de Buy Wenniger LM, Scheltema JM, Verheij J, et al. Testicular inflammation as a new manifestation of IgG4-associated disease. Urology. 2013;82:e15-6.

  73. Bösmüller H, von Weyhern CH, Adam P, et al. Paratesticular fibrous pseudotumor — an IgG4- related disorder? Virchows Arch. 2011;458:109-13.

  74. Karashima T, Taniguchi Y, Shimamoto T, et al. IgG4-related disease of the paratestis in a patient with Wells syndrome: a case report. Diagn Pathol. 2014;9:225.

  75. Hart PA, Moyer AM, Yi ES, et al. IgG4-related paratesticular pseudotumor in a patient with autoimmune pancreatitis and retroperitoneal fibrosis: an extrapancreatic manifestation of IgG4-related disease. Hum Pathol. 2012;43:2084-7.

  76. Yoshimura Y, Takeda S, Ieki Y, et al. IgG4-associated prostatitis complicating autoimmune pancreatitis. Intern Med. 2006;45:897-901.

  77. Uehara T, Hamano H, Kawakami M, et al. Autoimmune pancreatitis associated prostatitis: distinct clinicopathological entity. Pathol Int. 2008;58:118-25.

  78. Buijs J, de Buy Maillette, Wenniger L, et al. Immunoglobulin G4-related prostatitis: a case-control study focusing on clinical and pathologic characteristics. Urology. 2014;83:521-6.

  79. Hart PA, Smyrk TC, Chari ST. IgG4-related prostatitis: a rare cause of steroid-responsive obstructive urinary symptoms. Int J Urol. 2013; 20:132-4.

  80. Nishimori I, Kohsaki T, Onishi S, et al. IgG4-related autoimmune prostatitis: two cases with or without autoimmune pancreatitis. Intern Med. 2007;46:1983-9.

  81. Bourlon MT, Sánchez-Ávila M, Chablé-Montero F, et al. IgG4-related autoimmune prostatitis: is it an unusual or underdiagnosed manifestation of IgG4-related disease? Case Rep Urol. 2013;2013:295472.

  82. Nakai Y, Kagebayashi Y, Matsumoto Y, et al. IgG4-related prostatitis associated with retroperitoneal fibrosis: a case report. Hinyokika Kiyo. 2013;59:781-4.

  83. Saeki T, Nishi S, Imai N, et al. Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney Int. 2010;78:1016-23.

  84. Raissian Y, Nasr SH, Larsen CP, et al. Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol. 2011;22:1343-52.

  85. Khosroshahi A, Wallace ZS, Crowe JL, et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol. 2015;67:1688-99.

  86. Khosroshahi A, Carruthers MN, Deshpande V, et al. Stone rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine (Balt). 2012;91:57-66.

  87. Vasaitis L. IgG4-related disease: a relatively new concept for clinicians. Eur J Intern Med. 2016;27:1-9.




2020     |     www.medigraphic.com